Animal health reaches from clinic to outbreak and climate accounting
Congo’s Bundibugyo outbreak exposes a vaccine gap as human herpesvirus kills lemurs; a dog-mange trial and emissions from sick livestock reveal the costs of health across species.
Science··Evening
Bundibugyo fell outside stockpiles
Tom Fletcher, the UN humanitarian chief, said the Ebola outbreak in the Democratic Republic of Congo has killed at least 2,128 people out of more than 4,500 confirmed cases since it was declared on May 15, and described it as the fastest-growing outbreak on record. The strain is Bundibugyo, for which there is no approved vaccine or treatment; the stockpiles built during earlier Zaire-strain outbreaks do not apply to it. Cases have been reported across 6 provinces, with further cases in Uganda and near the border with South Sudan. Countries have pledged close to 300 million dollars, and the UN has released a further 30.5 million dollars from emergency funds. The account shows human outbreak response still hanging on a stockpiled strain, so a mismatched strain quickly makes a vaccine gap visible. At one end of the animal-health chain, before clinic tools, stockpile and field strain already fail to match.[1]
A human virus hits lemurs; clove oil hits dog mange
Veterinary researchers confirmed herpes simplex virus type 1 in 4 privately owned lemurs in the United States. All of them developed brain inflammation and died. It is the first time PCR testing has confirmed the human virus in lemurs; earlier reports relied on other laboratory methods. The cases, reported in the Journal of Zoo and Wildlife Medicine, span 8 years and involve 2 ring-tailed lemurs, 1 black-and-white ruffed lemur and 1 ruffed hybrid. One animal had taken part in a lemur yoga programme; co-author Jim Wellehan of the University of Florida says its infection was almost certainly linked to close contact with people, while the study cannot show that transmission happened in any particular session. Most adults carry the virus without symptoms, which is what makes routine close contact with primates risky. At the clinical end of the same health line, a 100-dog trial of a 7 percent clove oil preparation left all 20 high-dose dogs free of sarcoptic mange mites by day 14, against 10 of 20 on amitraz. Safety checks in 40 rats recorded no adverse effects in any study animal. By day 14, 2 low-dose and 12 medium-dose dogs were mite-free. The team calls the outcome proof of concept rather than validated clinical use; the work appears in Frontiers in Veterinary Science.[4], [3]
Sick herds also spoil the emissions ledger
Modelled farm data from Kenya and Tanzania put the cost of animal disease in emissions terms. Cattle losing a pregnancy raises emissions per kilogram of milk by 4 percent in Indigenous herds and by 15 percent in higher-yielding ones, and cutting calf mortality in western Kenya from 16 percent to 8 percent lowers methane per kilogram of beef by 3.2 percent. The write-up is by a researcher summarising work published in the journal animal, and it models herds rather than measuring whole-farm emissions directly. It also states the awkward part plainly: better animal health lowers emissions per unit of food, while more surviving animals can raise total methane in the atmosphere. The authors say the evidence is not yet strong or consistent enough for animal health to be counted in climate policy, and have set up the Halow initiative to test it. The Bundibugyo vaccine gap, lemur deaths from a human herpesvirus, a dog-mange trial and emissions from sick herds show health is more than a clinical matter: costs run through spillover, treatment trials and emissions per unit of food. Human and animal health are priced at once in stockpiles, contact, treatment and climate accounting.[2], [1], [4], [3]
